Be Familiar With the New Viral Vector Vaccines for COVID-19

March 2021

You'll hear buzz about "viral vector" COVID-19 vaccines.

Health Canada approved an interim order for the AstraZeneca (ChAdOx1-S) COVID-19 vaccine...and is currently reviewing the Johnson & Johnson/Janssen (Ad26.COV2.S) product.

These viral vector COVID-19 vaccines give our cells instructions to make the SARS-CoV-2 spike protein, to trigger an immune response...similar to the mRNA COVID-19 vaccines from Pfizer-BioNTech or Moderna.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

COVID-19 Be Familiar With the New Viral Vector Vaccines for COVID-19
Immunizations Help Reduce the Risk of Pain or Injury From IM Vaccinations
Substance Use Disorder Prevent Mix-Ups With New Buprenorphine Forms for Opioid Use Disorder
Mental Health Use Strategies to Keep Stress at Bay
Opioids Stay Vigilant When Dispensing Fentanyl Rxs
OTC Products Look for Cystoplus for Bladder Symptoms on OTC Shelves
Pediatrics Don't Kid Around With Pediatric Rxs
Asthma Expect Some Patients to Get One Inhaler to Prevent AND Relieve Asthma Attacks
Headache Ask if Emgality Is Being Used for Cluster Headaches or Migraine

Be Familiar With the New Viral Vector Vaccines for COVID-19

Practical advice for a better career, with unlimited access to CE

Table of Contents